CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
2.215
+0.005 (0.23%)
Apr 29, 2025, 4:00 PM EDT - Market closed
CollPlant Biotechnologies Revenue
In the year 2024, CollPlant Biotechnologies had annual revenue of $515.00K, down -95.30%. CollPlant Biotechnologies had revenue of $164.00K in the quarter ending December 31, 2024, a decrease of -45.15%.
Revenue (ttm)
$515.00K
Revenue Growth
-95.30%
P/S Ratio
49.26
Revenue / Employee
$9,035
Employees
57
Market Cap
25.37M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 515.00K | -10.44M | -95.30% |
Dec 31, 2023 | 10.96M | 10.66M | 3,565.22% |
Dec 31, 2022 | 299.00K | -15.34M | -98.09% |
Dec 31, 2021 | 15.64M | 9.50M | 154.86% |
Dec 31, 2020 | 6.14M | 3.82M | 164.75% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
CLGN News
- 14 days ago - CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies - PRNewsWire
- 4 weeks ago - CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE - PRNewsWire
- 5 weeks ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - PRNewsWire
- 2 months ago - CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia - PRNewsWire
- 2 months ago - CollPlant Biotechnologies Provides a Corporate Update - PRNewsWire
- 5 months ago - CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire